The Next Thing in Life Sciences Facility Design and Construction with Christopher R. DiPaolo, President and Founder of PROTECS
United Therapeutics Announces Ambitious Expansion Plan with New $100M Organ Production Facility in Silver Spring
Matan Companies Signs 198,000 SF Full-Building Lease with AstraZeneca at 700 Progress Way in Gaithersburg, MD
400,000 sf Building Opens Over 90% Leased – Anchored by Penn Medicine and Penn Engineering, and Numerous Commercial Tenants
South Duvall’s new three story building at 1450 Research Boulevard showcases the intersection of art and science [and technology] in biotech with a legacy mural by Justin Duvall.
Roquette, headquartered in La Madeleine, France, recently cut the ribbon on its new Pharmaceutical Innovation Center located near Philadelphia. The new $25 million center will complement the company’s existing innovation centers in France and Singapore to offer services and training to pharma companies in the U.S.
As one of the only new, Class A life science buildings delivering in 2023, Monument Innovation Center offers space to meet the demands and specific needs of a variety of scientific disciplines, from research and development to biotechnology and environmental sciences. Ideally located in Maryland’s leading life science corridor proximate to Washington D.C., it is in a prestigious cluster of established and emerging life science companies with access to top academic institutions, government agencies, and Montgomery County’s highly educated workforce.
Life sciences services provider CRB is establishing its latest office in New Jersey, creating a project delivery network corridor that ranges from the BioHealth Capital Region, through Philadelphia and on to Toronto.
Give Me Some Space! The Latest on Life Science Lab Spaces in Greater Philadelphia By Mark TerryApril 25, 2023 This section sponsored by ECBuild / EwingCole According to the Winter 2023 Philadelphia Life [….]
(SOURCE: Ensemble/Mosaic) Ensemble/Mosaic Signs First Lease at New Navy Yard Life Science Building with bioMérieux, Inc. PHILADELPHIA – March 29, 2023 – Ensemble/Mosaic, a joint venture between Ensemble Investments, LLC [….]
